Cargando…

Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4–19 years with epilepsy: a real-world study

This study determined the 24-month outcomes of perampanel treatment in children and adolescents with epilepsy. The percentage of ≥ 50% responders was 47.3% (139/294) at 12 months and 49.0% (144/294) at 24 months. A 100% reduction in seizures for more than 12 months was observed in 12.2% (36/294). Di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Youn, Song Ee, Kang, Hoon-Chul, Lee, Joon Soo, Kim, Heung Dong, Kim, Se Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474112/ https://www.ncbi.nlm.nih.gov/pubmed/37658098 http://dx.doi.org/10.1038/s41598-023-40594-8

Ejemplares similares

Adverse Events During Perampanel Adjunctive Therapy in Intractable Epilepsy
por: Youn, Song Ee, et al.
Publicado: (2018)

Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
por: Zhang, Wei-Ran, et al.
Publicado: (2023)

Adjunctive perampanel for glioma-associated epilepsy()
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018)

Perampanel is also a useful adjunctive treatment option in refractory epilepsy in children
por: Kim, Jon Soo, et al.
Publicado: (2019)

Real‐world analysis of hospitalizations in patients with epilepsy and treated with perampanel
por: Faught, Edward, et al.
Publicado: (2021)

Current role of perampanel in pediatric epilepsy
por: De Liso, Paola, et al.
Publicado: (2017)

Effect of adjunctive perampanel on the quality of sleep and daytime somnolence in patients with epilepsy
por: González-Cuevas, Montserrat, et al.
Publicado: (2016)

Adjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy
por: Renfroe, J. Ben, et al.
Publicado: (2019)

Utility and Safety of Perampanel in Pediatric FIRES and Other Drug-Resistant Epilepsies
por: Lim, Guo Yong, et al.
Publicado: (2021)

Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice
por: Lattanzi, Simona, et al.
Publicado: (2021)

Efficacy and tolerability of adjunctive perampanel treatment in children under 12 years of age with refractory epilepsy
por: Yun, Yuni, et al.
Publicado: (2019)

Effectiveness and tolerability of adjunctive perampanel in pediatric patients (aged 4–12 years) with refractory epilepsy: An observational study
por: Chu, Si-Jia, et al.
Publicado: (2022)

The efficacy and safety of adjunctive perampanel for the treatment of refractory focal‐onset seizures in patients with epilepsy: A meta‐analysis
por: Li, Yiming, et al.
Publicado: (2022)

Epilepsy Surgery in Pediatric Intractable Epilepsy with Destructive Encephalopathy
por: Park, So Young, et al.
Publicado: (2013)

Perampanel and childhood absence epilepsy: A real life experience
por: Operto, Francesca Felicia, et al.
Publicado: (2022)

Efficacy of perampanel in pediatric epilepsy with known and presumed genetic etiology
por: Miao, Pu, et al.
Publicado: (2023)

Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy
por: Yu, Lingyan, et al.
Publicado: (2023)

Perampanel in lissencephaly-associated epilepsy
por: Ikemoto, Satoru, et al.
Publicado: (2019)

Real-Life Effectiveness and Tolerability of Perampanel in Pediatric Patients Aged 4 Years or Older with Epilepsy: A Korean National Multicenter Study
por: Hwang, Su-Kyeong, et al.
Publicado: (2020)

Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study
por: Wheless, James, et al.
Publicado: (2020)

Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis
por: Zhang, Donger, et al.
Publicado: (2021)

Clinical Experience with Perampanel in Intractable Focal Epilepsy Over 12 Months of Follow-Up
por: Kim, Soo Yeon, et al.
Publicado: (2018)

Perampanel and Visuospatial Skills in Children With Epilepsy
por: Operto, Francesca Felicia, et al.
Publicado: (2021)

Psychiatric and Behavioural Side Effects Associated With Perampanel in Patients With Temporal Lobe Epilepsy. A Real-World Experience
por: Mammì, Anna, et al.
Publicado: (2022)

PROVE: Retrospective, non‐interventional, Phase IV study of perampanel in real‐world clinical care of patients with epilepsy
por: Wechsler, Robert T., et al.
Publicado: (2022)

Effects of Cannabidiol on Adaptive Behavior and Quality of Life in Pediatric Patients With Treatment-Resistant Epilepsy
por: Kim, Se Hee, et al.
Publicado: (2022)

Erratum: Effects of Cannabidiol on Adaptive Behavior and Quality of Life in Pediatric Patients With Treatment-Resistant Epilepsy
por: Kim, Se Hee, et al.
Publicado: (2023)

Cost-effectiveness of perampanel as an adjunctive treatment for uncontrolled focal seizures in pediatric patients: a Chinese perspective
por: Hu, Yani, et al.
Publicado: (2022)

Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study
por: Zhao, Ting, et al.
Publicado: (2023)

Clinical Features and Treatment Outcomes of Seronegative Pediatric Autoimmune Encephalitis
por: Lee, Sangbo, et al.
Publicado: (2021)

Efficacy of the Ketogenic Diet for Pediatric Epilepsy According to the Presence of Detectable Somatic mTOR Pathway Mutations in the Brain
por: Ko, Ara, et al.
Publicado: (2022)

Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy
por: Hsu, Warrington W. Q., et al.
Publicado: (2013)

Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children
por: Li, Dan, et al.
Publicado: (2022)

Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies
por: Rektor, Ivan, et al.
Publicado: (2020)

Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients
por: Gasparini, Sara, et al.
Publicado: (2022)

Cognitive effects of adjunctive perampanel for partial‐onset seizures: A randomized trial
por: Meador, Kimford J., et al.
Publicado: (2016)

Allopregnanolone and perampanel as adjuncts to midazolam for treating diisopropylfluorophosphate‐induced status epilepticus in rats
por: Dhir, Ashish, et al.
Publicado: (2020)

Erratum to: Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy
por: Hsu, Warrington W. Q., et al.
Publicado: (2013)

Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
por: Yi, Jia-Qin, et al.
Publicado: (2023)

Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)
por: Yamamoto, Takamichi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l5gur2ia9r2iqpg2kidn1ruei0